Olema Pharmaceuticals Inc

NASDAQ:OLMA  
32.96
+0.24 (+0.73%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Olema Pharmaceuticals, Inc. Stock, NASDAQ:OLMA

512 2nd Street, 4th floor, San Francisco, California 94107
United States of America
Phone: +1.415.651.3316
Number of Employees: 10

Description

Olema Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of targeted therapies for women's cancers. The company also focuses on OP-1250, a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD) that is being studied in a Phase 1/2 clinical trial for the treatment of metastatic or locally advanced ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Olema Pharmaceuticals was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.